Cao, Y. et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 614, 521–529 (2023).
Starr, T. N. et al. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains. PLoS Pathog. 18, e1010951 (2022).
Liu, Y. et al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature 602, 294–299 (2022).
Dadonaite, B. et al. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike. Cell 186, 1263–1278.e20 (2023).
Crawford, K. H. D. et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12, 513 (2020).
Roemer, C. & Neher, R. SARS-CoV-2 variant reports. GitHub https://github.com/neherlab/SARS-CoV-2_variant-reports/tree/main/reports (2023).
World Health Organization. Statement on the antigen composition of COVID-19 vaccines. WHO https://www.who.int/news/item/18-05-2023-statement-on-the-antigen-composition-of-covid-19-vaccines (2023).
Greaney, A. J., Starr, T. N. & Bloom, J. D. An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain. Virus Evol. 8, veac021 (2022).
Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024–1042.e21 (2020).
Haddox, H. K. et al. Jointly modeling deep mutational scans identifies shifted mutational effects among SARS-CoV-2 spike homologs. Preprint at bioRxiv https://doi.org/10.1101/2023.07.31.551037 (2023).
Starr, T. N. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 377, 420–424 (2022).
Cantoni, D. et al. Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike. EMBO Rep. 23, e54322 (2022).
McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332–2347.e16 (2021).
Bloom, J. D. & Neher, R. A. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol. 9, vead055 (2023).
Wang, Q. et al. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature https://doi.org/10.1038/s41586-023-06750-w (2023).
Wang, Q. et al. Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75. Cell Host Microbe 30, 1512–1517.e4 (2022).
Wang, Q. et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature 608, 603–608 (2022).
Bowen, J. E. et al. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines. Science 377, 890–894 (2022).
Addetia, A. et al. Neutralization, effector function and immune imprinting of Omicron variants. Nature 621, 592–601 (2023).
Taylor, A. L. & Starr, T. N. Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution. PLoS Pathog. 19, e1011901 (2023).
Yurkovetskiy, L. et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183, 739–751.e8 (2020).
Henderson, R. et al. Controlling the SARS-CoV-2 spike glycoprotein conformation. Nat. Struct. Mol. Biol. 27, 925–933 (2020).
Wang, Q. et al. Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern. iScience 24, 103393 (2021).
Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026–1039.e15 (2019).
Soltermann, F. et al. Quantifying protein–protein interactions by molecular counting with mass photometry. Angew. Chem. Int. Ed. 59, 10774–10779 (2020).
Hsieh, C.-L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501–1505 (2020).
Escalera, A. et al. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission. Cell Host Microbe 30, 373–387.e7 (2022).
Furusawa, Y. et al. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters. eBioMedicine 91, 104561 (2023).
Ke, Z. Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants. Preprint at bioRxiv https://doi.org/10.1101/2023.12.21.572824 (2023).
Low, J. S. et al. ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Science 377, 735–742 (2022).
Kaku, Y. et al. Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5. Lancet 23, e395–e396 (2023).
Farrell, A. G. et al. Receptor-binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2. Viruses 14, 2061 (2022).
Lempp, F. A. et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature 598, 342–347 (2021).
Liu, L. et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature 584, 450–456 (2020).
Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature 597, 97–102 (2021).
Zhao, Z. et al. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Nat. Commun. 13, 4958 (2022).
Zheng, B. et al. S373P mutation stabilizes the receptor-binding domain of the spike protein in omicron and promotes binding. JACS Au. 3, 1902–1910 (2023).
Dokainish, H. M. et al. The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein. eLife 11, e75720 (2022).
Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676–681 (2022).
Yang, T.-J. et al. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Nat. Struct. Mol. Biol. 28, 731–739 (2021).
Casalino, L. et al. Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein. ACS Cent. Sci. 6, 1722–1734 (2020).
Henderson, R. et al. Glycans on the SARS-CoV-2 spike control the receptor binding domain conformation. Preprint at bioRxiv https://doi.org/10.1101/2020.06.26.173765 (2020).
Miller, N. L., Clark, T., Raman, R. & Sasisekharan, R. Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain. Cell Rep. Med. 3, 100527 (2022).
Park, Y.-J. et al. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science 378, 619–627 (2022).
Volz, E. et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell 184, 64–75.e11 (2021).
Roemer, C. et al. SARS-CoV-2 evolution in the Omicron era. Nat. Microbiol. https://doi.org/10.1038/s41564-023-01504-w (2023).
Felsenstein, J. Phylogenies and the comparative method. Am. Nat. 125, 1–15 (1985).
Yisimayi, A. et al. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting. Preprint at bioRxiv https://doi.org/10.1101/2023.05.01.538516 (2023).
Thadani, N. N. et al. Learning from prepandemic data to forecast viral escape. Nature 622, 818–825 (2023).
Khan, K. et al. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant. Nat. Commun. 14, 8078 (2023).
Greaney, A. J. et al. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Sci. Transl. Med. 13, eabi9915 (2021).
Kim, K. et al. Measures of population immunity can predict the dominant clade of influenza A (H3N2) and reveal age-associated differences in susceptibility and specificity. Preprint at medRxiv https://doi.org/10.1101/2023.10.26.23297569 (2023).
Lee, J. M. et al. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin. eLife 8, e49324 (2019).
Li, Y. et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J. Exp. Med. 210, 1493–1500 (2013).
Bowen, J. E. et al. SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Sci. Immunol. 7, eadf1421 (2022).
Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020).
Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020).
Walls, A. C. et al. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 23, 899–905 (2016).
Pronker, M. F. et al. Sialoglycan binding triggers spike opening in a human coronavirus. Nature https://doi.org/10.1038/s41586-023-06599-z (2023).
Tortorici, M. A. et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481–489 (2019).
Song, X. et al. Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes. Nat. Commun. 12, 141 (2021).
Li, Z. et al. The human coronavirus HCoV-229E S-protein structure and receptor binding. eLife 8, e51230 (2019).
Dean, A. M. & Thornton, J. W. Mechanistic approaches to the study of evolution: the functional synthesis. Nat. Rev. Genet. 8, 675–688 (2007).
Blount, Z. D., Lenski, R. E. & Losos, J. B. Contingency and determinism in evolution: replaying life’s tape. Science 362, eaam5979 (2018).
Thorne, L. G. et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature 602, 487–495 (2022).
Jian, F. et al. Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding. PLoS Pathog. 19, e1011868 (2023).
Meijers, M., Ruchnewitz, D., Eberhardt, J., Łuksza, M. & Lässig, M. Population immunity predicts evolutionary trajectories of SARS-CoV-2. Cell 186, 5151–5164.e13 (2023).
Abousamra, E., Figgins, M. & Bedford, T. Fitness models provide accurate short-term forecasts of SARS-CoV-2 variant frequency. Preprint at medRxiv https://doi.org/10.1101/2023.11.30.23299240 (2024).
Dadonaite, B. & Bloom, J. XBB.1.5 full spike repository. Zenodo https://doi.org/10.5281/zenodo.10981249 (2024).
Dadonaite, B. & Bloom, J. XBB.1.5 RBD spike. Zenodo https://doi.org/10.5281/zenodo.10981257 (2024).
Dadonaite, B. & Bloom, J. BA.2 full spike. Zenodo https://doi.org/10.5281/zenodo.10981262 (2024).
Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682–687 (2020).
Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369, 1010–1014 (2020).
Voss, W. N. et al. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination. Preprint at bioRxiv https://doi.org/10.1101/2024.01.22.576742 (2024).
Zhou, T. et al. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science 376, eabn8897 (2022).